Barusiban
Подписчиков: 0, рейтинг: 0
| Clinical data | |
|---|---|
| ATC code |
|
| Identifiers | |
| |
| CAS Number | |
| PubChem CID | |
| ChemSpider | |
| UNII | |
| CompTox Dashboard (EPA) | |
| Chemical and physical data | |
| Formula | C40H63N9O8S |
| Molar mass | 830.06 g·mol−1 |
| 3D model (JSmol) | |
| |
| |
Barusiban (INN) (code name FE-200440) is a non-peptide drug which is among the most potent and selective oxytocin receptor antagonists known. It was trialed by Ferring Pharmaceuticals as a treatment of preterm labor but failed to demonstrate effectiveness and was not pursued any further.
See also
| Oxytocin |
|
||||||||
|---|---|---|---|---|---|---|---|---|---|
| Vasopressin |
|
||||||||
| Others |
|
||||||||